Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion.

No abstract is available for this paper.

• Publication year

  2019

• Venue

  American journal of clinical and experimental urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 30906803PMCID PMC6420704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma

  2019cited by this paper
• Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma

  2018influential reference
• The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors

  2018cited by this paper
• A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1

  2018cited by this paper
• Chicken Interferon-induced Protein with Tetratricopeptide Repeats 5 Antagonizes Replication of RNA Viruses

  2018cited by this paper
• Cancer statistics, 2018

  2018cited by this paper
• Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

  2018cited by this paper
• Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

  2018cited by this paper
• Recruitment of CCR2+ tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer

  2018cited by this paper
• IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling

  2018cited by this paper
• IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing.

  2018cited by this paper
• Renal cell carcinoma

  2017cited by this paper
• Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer

  2017cited by this paper
• Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.

  2016cited by this paper
• Epithelial to Mesenchymal Transition in Renal Cell Carcinoma: Implications for Cancer Therapy

  2016cited by this paper
• Anti-proliferative Properties of miR-20b and miR-363 from the miR-106a-363 Cluster on Human Carcinoma Cells.

  2016cited by this paper
• The Three Paralogous MicroRNA Clusters in Development and Disease, miR-17-92, miR-106a-363, and miR-106b-25

  2016cited by this paper
• Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

  2016cited by this paper
• Resveratrol Prevents Tumor Growth and Metastasis by Inhibiting Lymphangiogenesis and M2 Macrophage Activation and Differentiation in Tumor-associated Macrophages

  2016cited by this paper
• Prognosis of metastatic renal cell carcinoma with first‐line interferon‐α therapy in the era of molecular‐targeted therapy

  2016cited by this paper
• Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model.

  2016cited by this paper
• IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

  2015cited by this paper
• Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan

  2015cited by this paper
• Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma

  2014cited by this paper
• The somatic genomic landscape of chromophobe renal cell carcinoma.

  2014cited by this paper
• A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.

  2014influential reference
• High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis

  2014cited by this paper
• CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.

  2014cited by this paper
• Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages

  2014cited by this paper
• Broad and adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat protein IFIT5

  2014cited by this paper
• The Cancer Genome Atlas Research Network: A Sight to Behold

  2014cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• Chemotherapy in metastatic renal cell carcinoma today? A systematic review

  2013cited by this paper
• M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway

  2013influential reference
• IFIT5 potentiates anti-viral response through enhancing innate immune signaling pathways.

  2013cited by this paper
• Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway

  2013cited by this paper
• Growth-Promoting Role of the miR-106a∼363 Cluster in Ewing Sarcoma

  2013cited by this paper
• tRNA binding, structure, and localization of the human interferon-induced protein IFIT5.

  2013cited by this paper
• Interleukin-1 Assembles a Proangiogenic Signaling Module Consisting of Caveolin-1, Tumor Necrosis Factor Receptor–Associated Factor 6, p38–Mitogen-Activated Protein Kinase (MAPK), and MAPK-Activated Protein Kinase 2 in Endothelial Cells

  2012cited by this paper
• [A case of favorable response after combination treatment with interferon-α and cyclooxygenase-2 inhibitor against metastatic renal cell carcinoma].

  2012cited by this paper
• Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

  2011cited by this paper
• Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis

  2011cited by this paper
• Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation

  2009cited by this paper
• MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy

  2009cited by this paper
• Interferon-γ Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases*

  2009cited by this paper
• Interferon-alpha plus capecitabine and thalidomide in patients with metastatic renal cell cancer.

  2008cited by this paper
• Regulation of renal epithelial tight junctions by the von Hippel-Lindau tumor suppressor gene involves occludin and claudin 1 and is independent of E-cadherin.

  2008cited by this paper
• The antitumor effects of interferon: a personal history.

  2007cited by this paper
• Regulation of E-cadherin expression by VHL and hypoxia-inducible factor.

  2006cited by this paper
• VHL Promotes E2 Box-Dependent E-Cadherin Transcription by HIF-Mediated Regulation of SIP1 and Snail

  2006cited by this paper
• Interferon-γ induces regression of epithelial cell carcinoma: critical roles of IRF-1 and ICSBP transcription factors

  2006cited by this paper
• [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].

  2005cited by this paper
• Application of IL-2 and other cytokines in renal cancer

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.

  2004cited by this paper
• IL-1 is required for tumor invasiveness and angiogenesis

  2003influential reference
• Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells.

  2001cited by this paper
• IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

  2001cited by this paper
• Interferon in metastatic renal cell carcinoma.

  2000cited by this paper
• E-cadherin expression in renal cell cancer and its significance in metastasis and survival

  1996cited by this paper
• Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.

  1996cited by this paper
• E-cadherin expression in renal cell cancer and its significance in metastasis and survival.

  1995cited by this paper
• Complete response of metastatic renal cell carcinoma to low-dose interferon-gamma treatment.

  1995cited by this paper
• Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.

  1995cited by this paper
• Phase II trial of low dose gamma-interferon in metastatic renal cell carcinoma.

  1994cited by this paper
• Metastatic renal-cell carcinoma patients treated with interleukin 2 or interleukin 2 plus interferon gamma: immunological monitoring.

  1994cited by this paper
• Low-dose gamma-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burden.

  1994cited by this paper
• [Clinical study of immunotherapy with interferon alpha and gamma in metastatic renal cell carcinoma].

  1993cited by this paper
• [Results of low dosage cyclic interferon-gamma therapy of metastatic renal cell carcinoma].

  1993cited by this paper
• Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.

  1993cited by this paper
• Effect of interleukin-1-beta on metastasis formation in different tumor systems.

  1991cited by this paper
• Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma.

  1989cited by this paper
• Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

  1987cited by this paper
• Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens.

  1987cited by this paper
• Interferon therapy for the treatment of renal cancer

  1986cited by this paper
• Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2

  1985cited by this paper

• Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines.

  2025cites this paper
• Clinical Utility of IFIT Proteins in Human Malignancies

  2025influential citation
• The Dual Role of Interferon-γ in Tumor Immunity: Anti-Tumor and Pro-Tumor Effects

  2025cites this paper
• Analysis of the Mechanism Underlying Radiotherapy Resistance Caused by Oligodendroglia Cells in Glioblastoma by Applying the Single-cell RNA Sequencing Technology.

  2024cites this paper
• In silico profiling of the ADMET properties and inhibitory potentials of alkaloids against IFIT5 in renal cell carcinoma

  2024cites this paper
• 5-Fluorouracil-Loaded PLGA Declined Expression of Pro-Inflammatory Genes IL-9, IL-17A, IL-23 and IFN- y; in the HT-29 Colon Cancer Cell Line.

  2024cites this paper
• Epithelial−mesenchymal transition induced by tumor cell-intrinsic PD-L1 signaling predicts a poor response to immune checkpoint inhibitors in PD-L1-high lung cancer

  2024cites this paper
• Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability

  2024cites this paper
• Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease

  2024cites this paper
• IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway

  2024cites this paper
• A novel N7-Methylguanine-related gene signature for predicting prognosis in acute myeloid leukemia: bioinformatic analysis and experimental verification

  2024cites this paper
• Activity-Based Acylome Profiling with N-(Cyanomethyl)-N-(phenylsulfonyl)amides for Targeted Lysine Acylation and Post-Translational Control of Protein Function in Cells.

  2024cites this paper
• IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer

  2023cites this paper
• A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma

  2023cites this paper
• Inflammatory Networks in Renal Cell Carcinoma

  2023cites this paper
• Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide

  2023cites this paper
• Targeting MDK Abrogates IFN-γ-Elicited Metastasis inCancers of Various Origins

  2022cites this paper
• N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma

  2022cites this paper
• Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line

  2022cites this paper
• A proteome-wide atlas of lysine-reactive chemistry

  2021cites this paper
• A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma

  2020cites this paper
• Roles of IFN-γ in tumor progression and regression: a review

  2020cites this paper
• Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data

  2020cites this paper
• Epithelial-to-Mesenchymal Transition and its Association with PD-L1 and CD8 T cells in Thyroid Cancer

  2020cites this paper
• SAHA Overcomes 5-FU Resistance in IFIT2-Depleted Oral Squamous Cell Carcinoma Cells

  2020cites this paper
• Epithelial-to-mesenchymal transition and its association with PD-L1 and CD8 in thyroid cancer

  2020cites this paper
• Emerging Functions of Human IFIT Proteins in Cancer

  2019influential citation
• The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression

  2019cites this paper
• Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma

  2019cites this paper